2279 — Yonghe Medical Co Income Statement
0.000.00%
- HK$509.75m
- HK$1.04bn
- CNY1.78bn
- 24
- 65
- 10
- 19
Annual income statement for Yonghe Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,224 | 1,638 | 2,169 | 1,413 | 1,777 |
Cost of Revenue | |||||
Gross Profit | 889 | 1,222 | 1,580 | 873 | 997 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,126 | 1,372 | 1,912 | 1,574 | 2,309 |
Operating Profit | 98 | 266 | 256 | -162 | -532 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 71.5 | 231 | 210 | -109 | -585 |
Provision for Income Taxes | |||||
Net Income After Taxes | 35.6 | 163 | 120 | -85.9 | -547 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 35.6 | 163 | 120 | -85.9 | -546 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 35.6 | 163 | 120 | -84 | -538 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.069 | 0.317 | 0.329 | -0.164 | -0.986 |
Dividends per Share |